Physician profile
Kenneth Son
NPI 1417048331
$4,415.03
in general payments reported to CMS, 2019-2025
14 companies · $19.95 in 2025
The $19.95 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,819 · 2020: $225 · 2021: $455 · 2022: $439 · 2023: $1,333 · 2024: $125 · 2025: $19.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $755 · Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $755.14 |
| Food and Beverage | $722.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,253.53 | 2019-2020 | |
| Teleflex LLC | $1,106.84 | 2021-2023 | Urolift |
| Boston Scientific Corporation | $676.13 | 2019-2023 | |
| Uromedica, Incorporated | $265.01 | 2019 | |
| Axonics, INC. | $255.32 | 2021-2023 | Bulkamid |
| Astellas Pharma US INC | $207.53 | 2022-2024 | Veozah |
| Olympus America INC. | $193.51 | 2020-2022 | |
| Palette Life Sciences, INC. | $146.63 | 2023 | |
| Karl Storz Endoscopy-America | $140.21 | 2021 | |
| Pfizer INC. | $102.03 | 2022 | |
| Coloplast Corp | $28.70 | 2019 | |
| Abbvie INC. | $19.95 | 2025 | |
| Acacia Pharma INC | $13.65 | 2022 | |
| Procept Biorobotics Corporation | $5.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Son listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.